Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from HeraMED Ltd. ( (AU:HMD) ) is now available.
HeraMED Limited has issued 38,699,315 new fully paid ordinary shares on 2 April 2026, relying on provisions that allow the placement without a formal prospectus-style disclosure to investors. The move expands the company’s share base and may provide additional capital flexibility, while the board confirms ongoing compliance with financial reporting and continuous disclosure obligations.
The company also states that there is no excluded or undisclosed information that would be required for investors under the Corporations Act at the time of this notice. This assurance is intended to support secondary trading of the newly issued shares and maintain transparency for existing and prospective shareholders within the Australian regulatory framework.
The most recent analyst rating on (AU:HMD) stock is a Hold with a A$0.05 price target. To see the full list of analyst forecasts on HeraMED Ltd. stock, see the AU:HMD Stock Forecast page.
More about HeraMED Ltd.
HeraMED Limited (ASX:HMD) operates in the healthcare and medical technology sector, focusing on digital and connected solutions for maternal or broader health monitoring. The company targets patients, clinicians and healthcare providers seeking advanced, data-driven tools to support remote care and streamlined clinical workflows.
YTD Price Performance: 38.89%
Average Trading Volume: 917,875
Technical Sentiment Signal: Buy
Current Market Cap: A$55.81M
See more insights into HMD stock on TipRanks’ Stock Analysis page.